Robot component manufacturers are attracting massive capital flows as humanoid robotics accelerates, with some suppliers now commanding valuations that rival or exceed the robot makers themselves. In the first half of 2026, the domestic embodied intelligence sector completed 322 financing deals totaling 93.5 billion yuan, five times the figure from the same period in 2025, but most of this capital is flowing upstream to component makers rather than to robot body manufacturers like Unitree.

Why Are Robot Components More Valuable Than the Robots Themselves?

The answer lies in technical barriers and scarcity. Investment director Liu Diwei of Jinding Capital explained that the vast majority of nearly 1 trillion yuan in embodied intelligence financing went to "brain" manufacturers and model-side enterprises, which represent the core barrier in current humanoid robots. At the component level, the top three investment hotspots are joint modules, dexterous hands, and brain controllers. Dexterous hands are particularly emblematic of this trend. These highly integrated micro systems include micro motors, precision transmission, and force tactile sensors, making them extraordinarily complex to manufacture.

A high-performance five-finger dexterous hand on the market can cost up to hundreds of thousands of yuan, accounting for approximately 14 to 18 percent of the total cost of a humanoid robot. The extreme cost stems from high technical barriers, scarcity, and vulnerability to damage. Tesla's Optimus robot provides a cautionary example: its dexterous hand has a service life of only six weeks during training for sorting express parcels, yet costs over 6,000 US dollars per unit. When accounting for other vulnerable parts, the annual cost of replacing components for an in-service robot approaches 100,000 US dollars, or approximately 710,000 yuan.

What Are the Key Investment Hotspots in Robot Components?

• Dexterous Hands: High-performance five-finger dexterous hands represent 14 to 18 percent of total humanoid robot costs and command prices up to hundreds of thousands of yuan due to their complex micro-motor and sensor integration.
• Joint Modules: A humanoid robot requires approximately 28 joint actuators distributed across shoulders, elbows, hips, knees, and other parts, with hardware procurement accounting for about 30 percent of the bill of materials for the entire robot.
• Tactile Perception Systems: Companies like Yimu Technology are developing "electronic skin" technology that converts touch signals into data, allowing robots to understand objects through touch like humans do, addressing the industry pain point of robots that can reason but struggle to operate effectively.
• Brain Controllers: Control systems that manage robot movement and decision-making represent another critical component category attracting significant investment.

More than 20 enterprises in the embodied intelligence track now have valuations exceeding 100 billion yuan, with the top camp of the industry taking shape at an accelerated pace.

How Are Component Makers Capitalizing on This Trend?

Lingxin Qiaoshou, a core component manufacturer for humanoid robots, launched a new financing round in April 2026 with a target valuation of 6 billion US dollars, approximately 424 billion yuan. The company currently offers 7 series and more than 10 products with prices ranging from 3,999 yuan to 100,000 yuan, with monthly output reaching 1,000 units. According to industry data, in 2025, total dexterous hand sales reached 19,200 units, with In times Robotics shipping over 10,000 units and ranking first, while Lingxin Qiaoshou and BrainCo tied for second place.

Lingxin Qiaoshou plans to file for an initial public offering on the Hong Kong Stock Exchange in 2027, with some institutional investors predicting its valuation could reach one trillion yuan by then. In the second half of 2026, multiple robot component enterprises obtained financing intensively. Xinuo Future, a full-stack dexterous hand manufacturer, completed 500 million yuan in Series A+ financing led by Meituan, while Yimu Technology, which focuses on tactile perception, closed a Series E round exceeding 10 billion yuan with a post-money valuation surpassing 100 billion yuan.

How Does Unitree's Supply Chain Strategy Affect Component Makers?

Unitree's approach to component sourcing differs from competitors like Tesla. During its pre-IPO roadshow on August 7, 2026, Unitree founder Wang Xingxing outlined the company's strategy for managing its supply chain.

"Components that affect or restrict the core performance of robots, such as body structure, motion control system and joint modules, will continue to be independently developed. For functional components with diverse and scattered demands, the company will continue to purchase some models from external suppliers," stated Wang Xingxing.

Wang Xingxing, Founder of Unitree

This hybrid approach means that component suppliers like Changshu Bearing, DioMicro, Pantum Technology, and Shenzhen Huaqiang have established cooperative relationships with Unitree for functional modules and reducers. As Unitree moves forward with its listing process, these supply chain partners are expected to benefit from increased demand and the broader capital flows into the embodied intelligence sector.

Steps to Understanding the Robot Component Investment Boom

• Recognize the Technical Barrier: Component makers command premium valuations because they solve problems that affect every robot manufacturer, such as dexterous manipulation and tactile perception, which are harder to develop than robot body assembly.
• Track Financing Activity: Monitor funding rounds in component categories like dexterous hands, joint modules, and tactile sensors to identify which technical challenges investors believe will unlock the next phase of robotics growth.
• Analyze Supply Chain Dependencies: Examine which robot makers like Unitree are outsourcing components versus developing them in-house, as this reveals which component makers will capture the most demand and revenue.
• Watch IPO Timelines: Component makers like Lingxin Qiaoshou planning Hong Kong Stock Exchange listings in 2027 will provide public market validation of component valuations and profitability.

The concentration of capital in component manufacturing reveals a fundamental truth about the current state of humanoid robotics: the technology is still immature enough that component makers command higher valuations than integrators. This pattern typically reverses once an industry matures and integrators achieve scale. For now, however, investors are betting that the companies solving the hardest technical problems, not the companies assembling robots, will capture the most value.